CHLITINA HOLDING LIMITED (麗豐-KY) saw a significant profit boost in the second quarter, benefiting from a RMB 18 million (approximately NT$72.96 million) government subsidy recognized in its accounts. This subsidy contributed NT$0.88 to earnings per share (EPS), substantially higher than the Q1 EPS of NT$0.68. Coupled with a sales upturn in the Chinese mainland market following new product launches, analysts are optimistic about a strong quarterly profit performance, with potential for sustained momentum in the second half of the year.

Due to the appreciation of the New Taiwan dollar, CHLITINA’s June revenue totaled NT$284 million, a 5.91% year-on-year decline. Q2 revenue amounted to NT$952 million, down 6.42% year-on-year. The cumulative revenue for the first half of the year reached NT$1.75 billion, reflecting a 13.18% decrease compared to the same period last year.

However, when measured in RMB, June consolidated revenue was RMB 69 million, marking a 2% year-on-year increase. Q2 consolidated revenue in RMB was RMB 223 million, up 26% from Q1, indicating a gradual recovery in operations.

CHLITINA stated that the quarter-on-quarter revenue growth was mainly driven by strong shipments of multiple star functional new products and the seasonal rise in skincare demand during summer. This fueled synchronized growth across both online and offline channels, resulting in a 26% increase in quarterly revenue.

Looking ahead to Q3, CHLITINA maintains a cautiously optimistic outlook. Its flagship medical-grade new product line, the “Royal Extract Series,” features the world’s first high-performance anti-aging formula combining deer embryo active extract with PDRN active ingredients. Additionally, with the summer whitening peak approaching, several functional star products—including the nationally certified whitening and spot-fading “Crystal Diamond Whitening and Spot-fading Series” and the “Whitening Sunscreen”—are entering a hot sales cycle. These products are expected to continue strengthening CHLITINA’s brand presence in the mid-to-high-end consumer market, boosting overall customer spending and loyalty. This momentum is anticipated to contribute to steady operational growth for the group, with strong confidence in year-over-year monthly and quarterly revenue increases throughout the second half of the year.

Resource: 麗豐-KY第二季獲利吃大補丸 1,800萬人民幣財政補貼入帳